Financhill
Sell
22

NVO Quote, Financials, Valuation and Earnings

Last price:
$64.31
Seasonality move :
0.61%
Day range:
$64.16 - $65.79
52-week range:
$57.00 - $139.74
Dividend yield:
2.58%
P/E ratio:
19.05x
P/S ratio:
6.58x
P/B ratio:
14.22x
Volume:
8.1M
Avg. volume:
8.1M
1-year change:
-50.53%
Market cap:
$285.8B
Revenue:
$42.1B
EPS (TTM):
$3.38

Earnings Data

Next earnings date for NVO
Aug 06
2025
Most recent earnings per share
$0.92
Missed by $0.00
(May 7/2025)
Consensus Estimate
$0.92
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NVO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $12.7B -- -- $1.00 --
08/06/2025 Q2 $11.9B -- -- $0.94 --
05/07/2025 Q1 $11.9B $11B $0.92 $0.92 -$0.00
02/05/2025 Q4 $11.5B $12.2B $0.91 $0.80 $0.10
11/06/2024 Q3 $10.5B $10.5B $0.90 $0.86 $0.04
08/07/2024 Q2 $10.1B $9.8B $0.65 $0.71 -$0.06
05/02/2024 Q1 $9.1B $9.5B $0.83 $0.77 $0.05
01/31/2024 Q4 $8.9B $9.5B $0.71 $0.65 $0.06
11/02/2023 Q3 $8.1B $8.6B $0.73 $0.66 $0.07
08/10/2023 Q2 $8.2B $7.9B $0.63 $0.66 -$0.03
05/04/2023 Q1 -- $7.7B $0.63 -- --
02/02/2023 Q4 -- $6.6B $0.41 -- --
11/02/2022 Q3 -- $6.2B $0.43 -- --
08/04/2022 Q2 -- $5.9B $0.42 -- --
05/12/2022 Q1 -- $6.3B $0.47 -- --
02/02/2022 Q4 -- $5.9B $0.37 -- --
11/03/2021 Q3 -- $5.6B $0.42 -- --
08/04/2021 Q2 -- $5.4B $0.43 -- --
05/05/2021 Q1 -- $5.5B $0.44 -- --
02/03/2021 Q4 -- $5.1B $0.32 -- --
10/30/2020 Q3 -- $4.9B $0.35 -- --
08/06/2020 Q2 -- $4.4B $0.33 -- --
05/06/2020 Q1 -- $5B $0.37 -- --
02/05/2020 Q4 -- $4.8B $0.27 -- --
11/01/2019 Q3 -- $4.5B $0.32 -- --
08/09/2019 Q2 -- $4.5B $0.30 -- --
05/03/2019 Q1 -- $4.5B $0.33 -- --
02/04/2019 Q4 -- $4.5B $0.27 -- --
11/01/2018 Q3 -- $4.3B $0.29 -- --
08/08/2018 Q2 -- $4.4B $0.34 -- --
05/02/2018 Q1 -- $4.4B $0.36 -- --
02/01/2018 Q4 -- $4.4B $0.27 -- --
11/01/2017 Q3 -- $4.2B $0.31 -- --
08/09/2017 Q2 -- $4.2B $0.30 -- --
05/03/2017 Q1 -- $4.1B $0.29 -- --
02/02/2017 Q4 -- $4.3B $0.25 -- --
10/28/2016 Q3 -- $4.1B $0.29 -- --
08/05/2016 Q2 -- $4.2B $0.30 -- --
04/29/2016 Q1 -- $4B $0.27 -- --
02/03/2016 Q4 -- $4.2B $0.24 -- --
10/29/2015 Q3 -- $4B $0.24 -- --

Novo Nordisk AS Earnings Questions

  • How Much did Novo Nordisk AS Generate in Revenue Last Quarter?

    Novo Nordisk AS reported $11B worth of top line sales in its most recent quarter.

  • Did Novo Nordisk AS Beat Earnings Last Quarter?

    Novo Nordisk AS announced earnings per share of $0.92 which represents a miss of analyst forecast a $0.92 per share.

  • Is Novo Nordisk AS Profitable?

    Novo Nordisk AS reported $9.2B that represents $2.07 per share over the last quarter.

  • What is the Analyst Consensus for Novo Nordisk AS EPS Next Year?

    Novo Nordisk AS's earnings are forecast to grow from $3.28 per share to $3.06 per share next year representing an increase of 23.95%.

  • When is Novo Nordisk AS's Earnings Date?

    Novo Nordisk AS's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock